Literature DB >> 9515942

Acceleration of mammary tumorigenesis by exposure of 7,12-dimethylbenz[a]anthracene-treated female rats in a 50-Hz, 100-microT magnetic field: replication study.

M Mevissen1, M Häussler, A Lerchl, W Löscher.   

Abstract

In view of the methodological problems of epidemiological studies on associations between residential and occupational exposures to 50/60-Hz magnetic fields (MF) and increased incidence of cancers, laboratory studies are necessary to determine if 50/60-Hz MF can affect cancer development or growth. Recently, it was reported that alternating (50-Hz) MF of low flux density (100 microT) increase tumor growth and progression in a model of breast cancer in female rats in which mammary tumors were induced by the chemical carcinogen 7,12-dimethylbenz[a]anthracene (DMBA). The objective of the present study was to determine if a replicate experiment carried out in the same laboratory under the same experimental conditions yields a significant increase in tumor development and growth of similar magnitude. For the MF experiment, a group of 99 female Sprague-Dawley rats was exposed to a homogeneous horizontally polarized MF for 24 h/d (minus time for weighing, tumor palpation, cage cleaning, cage rotation), 7 d/wk; another group of 99 rats was sham exposed. DMBA was administered intragastrically at a dose of 5 mg/rat at the first day of exposure and at weekly intervals thereafter up to a total dose of 20 mg/rat. Duration of MF or sham exposure was 91 d. In both MF-exposed and sham-exposed rats, the first tumors could be recorded 6 wk after the initial DMBA application. At 9 wk after DMBA application, the group of MF-exposed rats exhibited significantly more animals with tumors than the sham-exposed group. This significant difference in the rate of tumor development was observed throughout the subsequent period of exposure. After autopsy, the incidence of macroscopically visible mammary tumors was 62% in controls, but 83% in MF-exposed rats, with the 35% difference between groups being statistically significant. Data substantiate that long-term exposure of DMBA-treated female Sprague-Dawley rats in an alternating MF of low flux density promotes the development and growth of mammary tumors, thus indicating that MF exposure exerts tumor-promoting and/or copromoting effects. Furthermore, the data show that the effects of MF exposure in the DMBA breast cancer model are reproducible if the same experiment is repeated in the same laboratory.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515942     DOI: 10.1080/009841098159259

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  5 in total

Review 1.  Assessing the potential carcinogenic activity of magnetic fields using animal models.

Authors:  J McCann; R Kavet; C N Rafferty
Journal:  Environ Health Perspect       Date:  2000-03       Impact factor: 9.031

2.  Effects on g2/m phase cell cycle distribution and aneuploidy formation of exposure to a 60 Hz electromagnetic field in combination with ionizing radiation or hydrogen peroxide in l132 nontumorigenic human lung epithelial cells.

Authors:  Hee Jin; Hye Eun Yoon; Jae-Seon Lee; Jae-Kyung Kim; Sung Ho Myung; Yun-Sil Lee
Journal:  Korean J Physiol Pharmacol       Date:  2015-02-25       Impact factor: 2.016

3.  Effect of 13 week magnetic field exposures on DMBA-initiated mammary gland carcinomas in female Sprague-Dawley rats.

Authors:  L E Anderson; G A Boorman; J E Morris; L B Sasser; P C Mann; S L Grumbein; J R Hailey; A McNally; R C Sills; J K Haseman
Journal:  Carcinogenesis       Date:  1999-08       Impact factor: 4.944

4.  Effect of 26 week magnetic field exposures in a DMBA initiation-promotion mammary gland model in Sprague-Dawley rats.

Authors:  G A Boorman; L E Anderson; J E Morris; L B Sasser; P C Mann; S L Grumbein; J R Hailey; A McNally; R C Sills; J K Haseman
Journal:  Carcinogenesis       Date:  1999-05       Impact factor: 4.944

5.  Effect of a magnetic field on Drosophila under supercooled conditions.

Authors:  Munekazu Naito; Shuichi Hirai; Makoto Mihara; Hayato Terayama; Naoyuki Hatayama; Shogo Hayashi; Masayuki Matsushita; Masahiro Itoh
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.